Table: Fuso Pharmaceutical - 6-MTH parent results

Fuso Pharmaceutical Industries

10/11/2023 04:40

Nov 10 (Reuters)- 
             Fuso Pharmaceutical Industries Ltd 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended       Year to 
                Sep 30, 2023        Sep 30, 2022     Mar 31, 2024 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             27.42               25.37            53.30    
                 (+8.1 pct)          (+1.6 pct)       (+4.5 pct)  
  Operating          1.10                1.29             2.00    
                 (-14.4 pct)         (+2.5 pct)       (-9.4 pct)  
  Recurring          1.10                1.40             2.00    
                 (-21.5 pct)         (+3.4 pct)       (-9.7 pct)  
  Net              717 mln               1.02             1.30    
                 (-29.6 pct)         (-2.4 pct)       (-19.0 pct) 
  EPS             82.18 yen          116.13 yen       148.21 yen  
  Ann Div                             70.00 yen        70.00 yen  
  -Q2 div         35.00 yen           30.00 yen                   
  -Q4 div                             40.00 yen        35.00 yen  
  
  NOTE - Fuso Pharmaceutical Industries Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4538.T